These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 33515423)

  • 1. Real-World Prescription Pattern and Healthcare Cost Among Patients with Ulcerative Colitis in Japan: A Retrospective Claims Data Analysis.
    Miyazaki C; Sakashita T; Jung W; Kato S
    Adv Ther; 2021 May; 38(5):2229-2247. PubMed ID: 33515423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between oral 5-ASA adherence and health care utilization and costs among patients with active ulcerative colitis.
    Mitra D; Hodgkins P; Yen L; Davis KL; Cohen RD
    BMC Gastroenterol; 2012 Sep; 12():132. PubMed ID: 23006789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Living with ulcerative colitis in Germany: a retrospective analysis of dose escalation, concomitant treatment use and healthcare costs.
    Dignass A; Waller J; Cappelleri JC; Modesto I; Kisser A; Dietz L; DiBonaventura M; Wood R; May M; Libutzki B; Bargo D
    J Med Econ; 2020 Apr; 23(4):415-427. PubMed ID: 31858853
    [No Abstract]   [Full Text] [Related]  

  • 4. Incidence, economic burden, and treatment of acute respiratory tract infection in hematopoietic stem cell transplantation recipients using real world data in Japan: a retrospective claims data analysis.
    Wattanakamolkul K; Nakayama Y
    J Med Econ; 2022; 25(1):870-879. PubMed ID: 35703058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Systematic Review of the Economic and Health-Related Quality of Life Impact of Advanced Therapies Used to Treat Moderate-to-Severe Ulcerative Colitis.
    Cichewicz A; Tencer T; Gupte-Singh K; Egodage S; Burnett H; Kumar J
    Adv Ther; 2023 May; 40(5):2116-2146. PubMed ID: 37000363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in Corticosteroid Prescriptions for Ulcerative Colitis and Factors Associated with Long-Term Corticosteroid Use: Analysis Using Japanese Claims Data from 2006 to 2016.
    Matsuoka K; Igarashi A; Sato N; Isono Y; Gouda M; Iwasaki K; Shoji A; Hisamatsu T
    J Crohns Colitis; 2021 Mar; 15(3):358-366. PubMed ID: 32845311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experience with Tofacitinib in Patients with Ulcerative Colitis: Data from a United States Claims Database.
    Chiorean M; Ha C; Hur P; Sharma PP; Gruben D; Khan NH
    Dig Dis Sci; 2023 Oct; 68(10):3985-3993. PubMed ID: 37639057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-Effectiveness Analysis of Vedolizumab Compared with Other Biologics in Anti-TNF-Naïve Patients with Moderate-to-Severe Ulcerative Colitis in Japan.
    Hernandez L; Kuwabara H; Shah A; Yamabe K; Burnett H; Fahrbach K; Koufopoulou M; Iwakiri R
    Pharmacoeconomics; 2020 Jan; 38(1):69-84. PubMed ID: 31552601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment Patterns in Newly Diagnosed Patients with Crohn's Disease Who Received Biologics Following Diagnosis: A Nationwide, Retrospective, Longitudinal, Observational Study Using a Medical Claims Database in Japan.
    Hirai F; Uda A; Ota M; Takemura Y; Tanaka K; Iwakiri R
    Digestion; 2023; 104(2):109-120. PubMed ID: 36450239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term direct and indirect costs of ulcerative colitis in a privately-insured United States population.
    Pilon D; Ding Z; Muser E; Obando C; Voelker J; Manceur AM; Kinkead F; Lafeuille MH; Lefebvre P
    Curr Med Res Opin; 2020 Aug; 36(8):1285-1294. PubMed ID: 32427006
    [No Abstract]   [Full Text] [Related]  

  • 11. Direct and indirect healthcare resource utilization and costs associated with ulcerative colitis in a privately-insured employed population in the US.
    Cohen R; Skup M; Ozbay AB; Rizzo J; Yang M; Diener M; Chao J
    J Med Econ; 2015 Jun; 18(6):447-56. PubMed ID: 25728698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of persistence with 5-aminosalicylic acid therapy for ulcerative colitis.
    Kane SV; Accortt NA; Magowan S; Brixner D
    Aliment Pharmacol Ther; 2009 Apr; 29(8):855-62. PubMed ID: 19183154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment patterns, healthcare resource utilization, and costs in patients with moderate-to-severe psoriasis treated with systemic therapy in Japan: A retrospective claims database study.
    Tada Y; Kim H; Spanopoulos D; Habiro K; Tsuritani K; Yamada Y; Mandal A; Zhong Y; Hikichi Y
    J Dermatol; 2022 Nov; 49(11):1106-1117. PubMed ID: 35946343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Healthcare resource utilization and treatment costs of Finnish chronic inflammatory bowel disease patients treated with infliximab
    Ylisaukko-Oja T; Torvinen S; Ventola H; Schmidt S; Herrala S; Kononoff J; Voutilainen M
    Scand J Gastroenterol; 2019 Jun; 54(6):726-732. PubMed ID: 31203693
    [No Abstract]   [Full Text] [Related]  

  • 15. Real life results in using 5-ASA for maintaining mild to moderate UC patients in Japan, a multi-center study, OPTIMUM Study.
    Nagahori M; Kochi S; Hanai H; Yamamoto T; Nakamura S; Omuro S; Watanabe M; Hibi T;
    BMC Gastroenterol; 2017 Apr; 17(1):47. PubMed ID: 28390410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Burden of narcolepsy in Japan: A health claims database study evaluating direct medical costs and comorbidities.
    Kamada Y; Imanishi A; Chiu SW; Yamaguchi T
    Sleep Med; 2024 Feb; 114():119-127. PubMed ID: 38181583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of a claims-based algorithm to identify cases of ulcerative colitis in Japan.
    Ogino H; Morikubo H; Fukaura K; Okui T; Gardiner S; Sugiyama N; Yoshii N; Kawaguchi T; Chen H; Nonnenmacher E; Setoguchi S; Nakashima N; Kobayashi T
    J Gastroenterol Hepatol; 2022 Mar; 37(3):499-506. PubMed ID: 34738649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-world assessment of therapy changes, suboptimal treatment and associated costs in patients with ulcerative colitis or Crohn's disease.
    Rubin DT; Mody R; Davis KL; Wang CC
    Aliment Pharmacol Ther; 2014 May; 39(10):1143-55. PubMed ID: 24697826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in the prevalence and incidence of ulcerative colitis in Japan and the US.
    Yamazaki M; Chung H; Xu Y; Qiu H
    Int J Colorectal Dis; 2023 May; 38(1):135. PubMed ID: 37204516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
    Burisch J
    Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.